
Webinar: Prognostic Tools in Breast Cancer Care
In collaboration with iBreastBook, Johan Hartman, co-founder of Stratipath, participated
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.

In collaboration with iBreastBook, Johan Hartman, co-founder of Stratipath, participated

Stratipath is thrilled to announce our active role in advancing

Stratipath is excited to announce the publication of a new

Swelife conducted an interview with our Chief Medical Officer and

Stratipath was honored with the Dream Award at the Techarenan

Seminar – Almedalen. ”AI can predict relapse in breast cancer

Stratipath is thrilled to announce a collaboration with Roche, the

Stratipath is excited to announce the publication of a new

Stratipath Breast, is now officially registered with the Medicines and

Stratipath co-founder Professor Johan Hartman, is discussing the future of

Mattias Rantalainen, co-founder, CTO of Stratipath, and coordinator of SwAIPP

MedTechLabs labs recently interviewed our CEO, Fredrik Wetterhall, discussing the